Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis

NCT02775045 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT02775045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02775045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
Lead sponsor
University of Wisconsin, Madison
Phase
Observational
Overall status
Completed
Start date
August 30, 2016
Completion date
December 13, 2018
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis